Fasting Insulin and Metabolic Health

Most people who have had routine blood work know their glucose and A1c. Fasting insulin receives far less attention.

That leaves out an important part of glucose regulation.

Glucose tells us how much sugar is circulating in the blood. Insulin helps us understand some of the work being done to keep that glucose under control.

A person may maintain a normal fasting glucose because the pancreas is producing enough insulin to compensate for declining insulin sensitivity. That compensation may be present well before glucose reaches the range used to diagnose prediabetes or diabetes.

Fasting insulin can help us see that part of the metabolic picture earlier.

For a broader discussion, read Metabolic Health and Insulin Resistance: A Longevity Medicine Guide.

What Fasting Insulin Measures

Insulin is produced by the beta cells of the pancreas. After we eat, insulin helps move glucose into muscle, liver, and other tissues and helps regulate the storage and use of energy.

Fasting insulin measures the amount of insulin circulating after a period without food, usually an overnight fast.

In someone with good insulin sensitivity, the body generally requires less insulin to maintain fasting glucose. As tissues become less responsive to insulin, the pancreas may compensate by producing more.

That compensation can work remarkably well for a long time.

Glucose may remain within the laboratory reference range because the pancreas is still keeping up with demand. Looking only at glucose can therefore miss the amount of insulin required to maintain that result.

Normal Glucose Does Not Always Mean Normal Insulin Physiology

Fasting glucose and A1c remain important clinical tests. They are the established tools used to screen for and diagnose prediabetes and diabetes.

They answer different questions from fasting insulin.

Fasting glucose is a snapshot of blood glucose after fasting. A1c estimates average glucose exposure over the previous several months. Neither directly measures how much insulin the pancreas is producing to maintain that glucose.

During compensated insulin resistance, insulin production may rise while fasting glucose remains relatively stable. Eventually, if pancreatic compensation becomes inadequate, glucose begins to rise more consistently.

This is one reason we do not assume that a normal glucose or A1c automatically means that insulin sensitivity is optimal.

Fasting Insulin Is Useful, but It Is Not a Diabetes Test

Fasting insulin should not be confused with the diagnostic criteria for diabetes.

The American Diabetes Association uses fasting plasma glucose, the two-hour glucose result from an oral glucose tolerance test, A1c, or a random plasma glucose in the appropriate clinical setting to diagnose diabetes.

Fasting insulin is not part of those diagnostic criteria.

We use it for a different purpose. It can provide additional information when we are trying to understand insulin sensitivity, metabolic compensation, body composition changes, or a lipid pattern that does not make sense from glucose alone.

There Is No Universal “Optimal” Fasting Insulin Number

Fasting insulin is often presented online with precise cutoffs separating optimal, borderline, and insulin-resistant ranges. The laboratory science does not support that level of precision.

Commercial insulin assays still vary considerably. A 2025 comparison of widely used insulin assays found substantial differences between methods despite efforts at standardization.

This makes it difficult to establish one fasting insulin cutoff that can be applied equally across every laboratory, population, and clinical situation.

We generally prefer lower insulin requirements when glucose regulation, nutrition, body composition, and the rest of the clinical picture are appropriate. We are also interested in direction. A fasting insulin that has steadily increased while visceral fat, triglycerides, or glucose are moving in the same direction is often more informative than comparing one result with an internet target.

When following fasting insulin over time, using the same laboratory when practical can make the trend easier to interpret.

Fasting Insulin and HOMA-IR

Fasting insulin can be interpreted together with fasting glucose using HOMA-IR, the Homeostatic Model Assessment of Insulin Resistance.

HOMA-IR provides an estimate of insulin resistance based on the relationship between fasting insulin and fasting glucose.

It is still a surrogate measurement. The hyperinsulinemic-euglycemic clamp remains the research gold standard for directly assessing insulin sensitivity, but it is far too cumbersome for routine clinical use.

HOMA-IR gives clinicians a practical way to consider glucose and insulin together. Like fasting insulin itself, interpretation depends on the patient, the laboratory method, and the broader metabolic picture.

Read more in HOMA-IR and Insulin Resistance.

Fasting Insulin, Triglycerides, and HDL

Insulin resistance frequently leaves a recognizable pattern on the lipid panel.

The liver may produce more triglyceride-rich VLDL particles. Triglycerides rise, HDL may fall, and the composition of LDL particles can change.

This is why we often look at fasting insulin alongside triglycerides, HDL, and the triglyceride-to-HDL ratio.

A higher TG:HDL ratio can be a useful clue to insulin-resistant lipid metabolism, although it does not directly measure insulin resistance and should not replace fasting insulin, ApoB, or other appropriate testing.

Related reading: Triglyceride-to-HDL Ratio and Metabolic Health.

Where ApoB Fits

Metabolic dysfunction can also change the relationship between LDL cholesterol and the number of atherogenic particles in circulation.

In some people with insulin resistance and higher triglycerides, LDL particles carry less cholesterol individually while the total number of ApoB-containing particles increases. LDL-C may therefore look less concerning than the particle burden actually is.

ApoB can help identify that discordance.

Fasting insulin and ApoB are not competing tests. Fasting insulin helps describe metabolic regulation. ApoB estimates atherogenic particle burden. Both can be useful when a routine lipid panel does not tell the whole story.

See ApoB vs LDL-C: What Actually Matters?.

Visceral Fat Often Tells Part of the Same Story

Insulin resistance and visceral fat frequently travel together, but body weight is not a reliable substitute for body composition.

Someone can have a body mass index within the conventional normal range and still carry a disproportionate amount of fat around the abdominal organs. Another person can weigh considerably more because of greater lean mass and have a very different metabolic profile.

Visceral adipose tissue is metabolically active and is strongly associated with insulin resistance and cardiometabolic risk.

When fasting insulin is rising, changes in waist circumference, visceral fat, lean mass, and overall body composition can help explain what is happening.

This is one reason we use DEXA and SECA body composition testing in selected patients rather than relying exclusively on body weight or BMI.

Explore Body Composition and Longevity Medicine.

Fatty Liver and Fasting Insulin

The liver is deeply involved in insulin resistance.

When hepatic insulin sensitivity declines, regulation of glucose production and lipid metabolism becomes less efficient. Triglyceride production may increase, liver fat can accumulate, and fasting insulin often rises as part of the broader metabolic pattern.

A person does not need to have diabetes for this process to be underway.

ALT and AST can provide useful information, but normal liver enzymes do not completely exclude metabolic dysfunction or excess liver fat. Clinical history, triglycerides, body composition, glucose regulation, and imaging findings may add context when metabolic-associated steatotic liver disease is a concern.

Sleep, Stress, and Insulin Sensitivity

Insulin sensitivity is not determined by food alone.

Short sleep, untreated sleep apnea, circadian disruption, inactivity, chronic stress, and some medications can affect glucose and insulin regulation. Acute illness can alter the picture as well.

This becomes relevant when a fasting insulin result does not fit the rest of the patient's history.

One laboratory value should not be interpreted without asking what was happening around the time it was measured.

Sleep apnea is especially important because it is associated with insulin resistance, hypertension, cardiovascular risk, and changes in body composition even when someone believes they are spending enough hours in bed.

Explore Sleep and Recovery in Longevity Medicine.

Menopause, Body Composition, and Insulin Sensitivity

Metabolic changes around midlife are not unusual.

During the menopause transition, changes in estrogen signaling, sleep, physical activity, muscle mass, and fat distribution can influence insulin sensitivity. Some women notice more abdominal fat or greater difficulty maintaining the same body composition despite little change in body weight.

That does not mean every metabolic change in midlife is caused by hormones. It does mean that glucose regulation, fasting insulin, body composition, sleep, exercise, and hormone status may need to be considered together rather than as separate problems.

Read more about Hormone Transitions and Longevity Medicine.

Fasting Insulin and Cardiovascular Risk

Insulin resistance commonly clusters with several established cardiovascular risk factors, including hypertension, higher triglycerides, visceral adiposity, fatty liver, inflammation, and atherogenic dyslipidemia.

Prospective studies have also found associations between higher fasting insulin and later hypertension and coronary heart disease, although fasting insulin should not be treated as an independent cardiovascular risk score.

For cardiovascular prevention, we are more interested in the complete picture. That includes blood pressure, ApoB, LDL-C, non-HDL-C, triglycerides, Lp(a), smoking, kidney function, metabolic health, family history, body composition, and evidence of existing atherosclerosis when imaging is appropriate.

Explore Preventive Cardiology and Cardiometabolic Health.

The Brain and Insulin Resistance

Insulin also functions in the brain, where it participates in energy regulation, cellular signaling, synaptic function, and other processes relevant to cognition.

Research has linked systemic insulin resistance and metabolic dysfunction with cognitive decline and neurodegenerative risk. The biology is still being worked out, and a fasting insulin result cannot diagnose insulin resistance in the brain.

From a longevity perspective, the connection is another reason to take metabolic health seriously before diabetes develops.

Related reading: Fasting Insulin and Brain Health.

Getting a Useful Fasting Insulin Result

Fasting insulin is most useful when the testing conditions are reasonably consistent.

An overnight fast is typically used. Water is generally fine unless the laboratory gives different instructions. A large meal late the night before, alcohol, acute illness, unusually strenuous exercise, significant sleep disruption, or medications that affect glucose metabolism can influence the result.

If an insulin value is unexpected, repeating it under standardized conditions may be more useful than building a treatment plan around one unusual measurement.

Trends are especially helpful when they are accompanied by changes in fasting glucose, A1c, triglycerides, HOMA-IR, visceral fat, or body composition.

How We Use Fasting Insulin at HormoneSynergy®

Fasting insulin is rarely interesting by itself.

We use it as one part of a metabolic assessment that may include:

• Fasting glucose
• Hemoglobin A1c
• HOMA-IR
• Triglycerides and HDL
• ApoB and non-HDL cholesterol
• Lipoprotein(a) when appropriate
• Liver enzymes and liver health
• Blood pressure
• DEXA or SECA body composition
• Visceral fat
• Muscle mass
• Sleep and possible sleep apnea
• Exercise and physical fitness
• Nutrition and alcohol intake
• Medications
• Hormone status when clinically relevant
• Personal and family cardiovascular history

A fasting insulin result becomes useful when it helps explain the rest of the patient.

Someone with normal glucose, increasing fasting insulin, rising triglycerides, and increasing visceral fat has a different metabolic picture from someone with the same fasting insulin who is lean, highly active, and has stable glucose and lipids.

That is why we do not treat a laboratory number without understanding the physiology around it.

What Can Improve an Unfavorable Insulin Pattern?

The first step is identifying what is driving it.

For many people, improving insulin sensitivity involves losing excess visceral fat when present, preserving or increasing skeletal muscle, regular resistance training, aerobic activity, improved sleep, adequate protein, better overall food quality, and reducing excess alcohol or highly refined foods.

Weight loss can improve insulin sensitivity when excess adiposity is contributing to the problem, but weight loss is not the only objective. Maintaining muscle becomes increasingly important with age and is particularly important during medical weight loss.

Medication may also be appropriate depending on the clinical situation. Treatment decisions should be based on the underlying condition and overall metabolic risk rather than an isolated fasting insulin result.

Frequently Asked Questions

What does fasting insulin measure?

Fasting insulin measures the concentration of insulin circulating after an overnight fast. It can provide information about how much insulin the body is using to maintain fasting glucose.

Can fasting insulin be high when fasting glucose is normal?

Yes. During compensated insulin resistance, the pancreas may produce more insulin to maintain glucose within the normal range. This can occur before fasting glucose or A1c becomes abnormal.

What is a normal fasting insulin level?

Laboratory reference ranges vary, and there is no universally accepted fasting insulin cutoff for diagnosing insulin resistance. Insulin assays also differ between laboratories. Results are best interpreted with fasting glucose, HOMA-IR, body composition, lipids, medical history, and trends over time.

Is fasting insulin used to diagnose diabetes?

No. Diabetes is diagnosed using established glucose and A1c criteria. Fasting insulin can provide additional metabolic information but is not one of the standard diagnostic tests for diabetes.

What is the difference between fasting insulin and HOMA-IR?

Fasting insulin is a measured laboratory value. HOMA-IR combines fasting insulin and fasting glucose in a calculation that estimates insulin resistance.

Can fasting insulin be useful if A1c is normal?

Yes. A1c reflects average glucose exposure. Fasting insulin can provide additional information about how much insulin may be required to maintain that glucose control.

Does high fasting insulin mean I have insulin resistance?

It can raise suspicion for insulin resistance, but one value should not be used as a diagnosis. Laboratory method, fasting conditions, medications, body composition, glucose, HOMA-IR, triglycerides, and the rest of the clinical picture all matter.

How often should fasting insulin be checked?

There is no universal testing interval. Repeat testing depends on why it was ordered, the initial result, changes in treatment or body composition, and the broader metabolic risk profile.

References

• American Diabetes Association Professional Practice Committee. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes 2026. Diabetes Care. 2026;49(Suppl 1).
• Rohlfing C, Petroski G, Hatten-Beck M, et al. The current status of serum insulin measurements and the need for standardization. Clinical Chemistry and Laboratory Medicine. 2025;63(12):2442-2446. PMID: 40802520.
• Mini-review on insulin resistance assessment: Advances in surrogate indices and clinical applications. World Journal of Clinical Cases. 2025;13(29):108380. PMID: 40933937.
• Xun P, Wu Y, He Q, He K. Fasting insulin concentrations and incidence of hypertension, stroke, and coronary heart disease: a meta-analysis of prospective cohort studies. American Journal of Clinical Nutrition. 2013;98(6):1543-1554.

Editorial Note

This article is part of the HormoneSynergy® longevity medicine education library. It is intended for general education and does not replace individualized medical care. Fasting insulin and other metabolic markers should be interpreted in the context of the patient's medical history, medications, laboratory method, body composition, lifestyle, and other relevant clinical findings.